Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Neoprobe's Lymphoseek achieves primary endpoint in phase III trial

Dec. 9, 2009

FDA approves Roche's test to screen source plasma for HIV, HBV and HCV

Dec. 7, 2009

ExonHit Therapeutics launches AclarusDx Alzheimer's test

Dec. 4, 2009

Wilex receives preliminary results of phase III Redectane trial

Dec. 3, 2009

FDA clears ProParaflu+ parainfluenza assay for marketing

Dec. 2, 2009

FDA approves Avioq HIV-1 microelisa system for detection of antibodies against HIV-1

Dec. 2, 2009

Clarient is granted exclusive right to commercialize MUC1* diagnostic cancer test

Dec. 2, 2009

Photocure's NDA for Hexvix to be reviewed by FDA in December 2009

Nov. 30, 2009

HairDX launches HairDX (RxR) genetic test to assess risk for BPH and response to finasteride

Nov. 23, 2009

Clinical Data starts phase III Stedivaze trial for cardiac stress testing

Nov. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.